Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib + atorvastatin vs ezetimibe + atorvastatin vs placebo + atorvastatin in Japanese primary hypercholesterolemia
jRCT2080222726Phase 3
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of evacetrapib in hypercholesterolemia (3 arms), sponsored by Eli Lilly and Company.
02
Drugs
evacetrapib
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on jRCT2080222726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222726.